Synmosa Biopharma Corp(TW:4114)
NT$27.75-0.10 (-0.36%)
TW:4114
Synmosa Biopharma Corp Revenue
NT$27.75
At close:-0.10 (-0.36%)
Synmosa Biopharma Corp (4114) Revenue
Synmosa Biopharma Corp Revenue
Synmosa Biopharma Corp had a revenue of 1.92B in the quarter ending Jun 30, 2026, with 18.08%. This bring the company's revenue in the last twelve months to 6.68B, Increased 4.86%. In the fiscal year ending Dec 31, 2025, Synmosa Biopharma Corp had annual revenue of 6.19B with 11.53% growth.
- Revenue (ttm)
- 6.68B
- Revenue Growth
- 11.40%
- P/S Ratio
- 2.42
- Revenue/Employee
- TWD 12,503,560
- Employees
- 495
- Market Cap
- TWD 14.97B
Revenue Chart
Synmosa Biopharma Corp Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.19B | 639.71M | 11.53% |
| Dec 31, 2024 | 5.55B | 409.05M | 7.96% |
| Dec 31, 2023 | 5.14B | 754.13M | 17.19% |
| Dec 31, 2022 | 4.39B | 1.15B | 35.59% |
| Dec 31, 2021 | 3.23B | 196.67M | 6.47% |
| Dec 31, 2020 | 3.04B | 359.38M | 13.42% |
| Dec 31, 2019 | 2.68B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.